This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walsh, S. Articles by Loda, M. Search for Related Content PubMed PubMed Citation Articles by Walsh, S. Articles by Loda, M.

(American Journal of Pathology. 1999;155:1511-1518.)
© 1999 American Society for Investigative Pathology

Regular Articles

p27 Expression in Inflammatory Bowel Disease-Associated Neoplasia

Further Evidence of a Unique Molecular Pathogenesis

Shaun Walsh^*, Michael Murphy^*, Mark Silverman, Robert Odze, Donald Antonioli^*, Harvey Goldman^* and Massimo Loda^§

From the Department of Pathology,^*
Beth Israel Deaconess Medical Center, Boston; the Department of Pathology,
Lahey-Hitchcock Medical Center, Burlington; the Department of Pathology,
Brigham and Women’s Hospital, Boston; and the Department of Adult Oncology,^§
Dana Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts

The cyclin-dependent kinase inhibitor p27 is a negative regulator of the transition from G1 to S phase of the cell cycle, protects against inflammatory injury and promotes epithelial differentiation. Because p27 protein has been shown to be abnormally expressed both in dysplasia associated with Barrett’s esophagus and in sporadic colorectal adenomas, we used immunohistochemistry to evaluate p27 expression in inflammatory bowel disease (IBD)-associated dysplasia and carcinomas. Normal, inflamed, and transitional mucosa, sporadic adenomas, and sporadic colonic carcinomas were studied as controls. In normal colonic epithelium p27 expression was restricted to the superficial, terminally differentiated cells. In colitic and inflamed diverticular mucosa p27 was expressed in the base of the crypts in 86 and 70% of cases, respectively. Similarly, in transitional mucosa adjacent to sporadic carcinomas p27 was expressed in the base of the crypts in all cases. Strong p27 expression extended more frequently from the base of the crypts to superficial cells in IBD-associated dysplasia than in sporadic adenomas (P < 0.007). Twenty of 20 (100%) IBD-associated carcinomas showed low p27 expression (<50% nuclei positive) compared to 6 of 20 (30%) stage-matched sporadic colorectal carcinomas (P < 0.001). We conclude (i) aberrant p27 protein expression in inflamed and IBD-associated nondysplastic mucosa is indistinguishable from that found in transitional mucosa adjacent to sporadic carcinomas; (ii) p27 is overexpressed in dysplastic lesions, perhaps as an attempt to counterbalance proliferative stimuli; and (iii) IBD-associated colorectal carcinomas have significantly lower p27 expression, commonly associated with poor prognosis, than stage-matched sporadic colorectal carcinomas. These findings further substantiate the existence of divergent molecular pathogenetic pathways between these types of carcinomas and suggest an intrinsically more aggressive behavior of IBD-associated colon carcinomas compared to sporadic ones.

This article has been cited by other articles:

				J. Malaterre, M. Carpinelli, M. Ernst, W. Alexander, M. Cooke, S. Sutton, S. Dworkin, J. K. Heath, J. Frampton, G. McArthur, et al. c-Myb is required for progenitor cell homeostasis in colonic crypts PNAS, March 6, 2007; 104(10): 3829 - 3834. [Abstract] [Full Text] [PDF]

				T. Kucharzik, S. V. Walsh, J. Chen, C. A. Parkos, and A. Nusrat Neutrophil Transmigration in Inflammatory Bowel Disease Is Associated with Differential Expression of Epithelial Intercellular Junction Proteins Am. J. Pathol., December 1, 2001; 159(6): 2001 - 2009. [Abstract] [Full Text] [PDF]

				S. J. Urbanski and F. Fogt Dysplasia in Chronic Ulcerative Colitis: A Molecular Approach to Its Differential Diagnosis International Journal of Surgical Pathology, January 1, 2000; 8(1): 11 - 16. [Abstract] [PDF]